Page last updated: 2024-08-24

azelnidipine and Anterior Choroidal Artery Infarction

azelnidipine has been researched along with Anterior Choroidal Artery Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Al-Mudhafar, A; Fakharaldeen, Z; Hadi, N; Radhi, A1
Hirano, T; Okamoto, S; Shiraishi, S; Tomiguchi, S; Uchino, M; Watanabe, M1

Trials

1 trial(s) available for azelnidipine and Anterior Choroidal Artery Infarction

ArticleYear
Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:1

    Topics: Aged; Azetidinecarboxylic Acid; Blood Pressure; Brain Ischemia; Calcium Channel Blockers; Cerebral Infarction; Cerebrovascular Circulation; Dihydropyridines; Female; Follow-Up Studies; Functional Laterality; Heart Rate; Humans; Hypertension; Image Processing, Computer-Assisted; Iofetamine; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Stroke; Tomography, Emission-Computed, Single-Photon

2010

Other Studies

1 other study(ies) available for azelnidipine and Anterior Choroidal Artery Infarction

ArticleYear
Potential protective effects of Azelnidipine against cerebral ischemia-reperfusion injury in male rats.
    Journal of medicine and life, 2022, Volume: 15, Issue:11

    Topics: Animals; Antioxidants; Brain Ischemia; Cerebral Infarction; Intercellular Adhesion Molecule-1; Interleukin-10; Interleukin-6; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha

2022